Reilley, M. ., Bailey, A. ., , Janku, F. ., Naing, A. ., Falchook, G. ., … Hong, D. . Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. Journal for Immunotherapy of Cancer, 5, 35. https://doi.org/10.1186/s40425-017-0238-1 (Original work published 2017)

Adashek, J. ., Subbiah, I. ., Matos, I. ., Garralda, E. ., Menta, A. ., Ganeshan, D. ., & . (2020). Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?. Trends in Cancer, 6(3), 181-191. https://doi.org/10.1016/j.trecan.2020.01.005